Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label Study Assessing the Efficacy of Erenumab on Functional Impact of Migraine

NCT04465357 is registered in ClinicalTrials.gov with Merle Diamond as lead sponsor.

NCT NCT04465357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04465357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label Study Assessing the Efficacy of Erenumab on Functional Impact of Migraine
Lead sponsor
Merle Diamond
Phase
Phase 4
Overall status
Completed
Start date
October 22, 2020
Completion date
June 3, 2022
Enrollment
55 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

migraine